CD4 and common variable immunodeficiency: Malphettes et al. identified a subgroup of CVID patients enrolled in the DEFI cohort study, characterized by the occurrence of opportunistic infections (OIs) and/or a CD4+ T cell count of <200 cells/μL, and showed significant differences from classic CVID patients in terms of clinical and immunologic characteristics.